BCL2L1 and melanoma: To explore whether HHT-induced alternative splicing has potential relevance in cancer treatment, we examined the effect of HHT on the alternative splicing of Bcl-x and Caspase 9 in human non-small cell lung cancer A549 cells and human malignant melanoma UACC903 cells (Fig. 3).